Applied DNA Sciences, Inc. (NASDAQ:APDN) Files An 8-K Regulation FD Disclosure

Applied DNA Sciences, Inc. (NASDAQ:APDN) Files An 8-K Regulation FD Disclosure
Item 7.01

Regulation FD Disclosure
Story continues below

As previously reported on a Current Report on Form 8-K of Applied DNA Sciences, Inc. ( the “Company”) dated December 26, 2018, on such date the Company closed a public offering (the “Offering”) of an aggregate of 5,500,000 shares of common stock, par value $0.001 per share (the “Common Stock”), together with warrants to purchase an aggregate of 5,500,000 shares of common stock (the “Warrants”) at an exercise price equal to $0.50 per share of Common Stock with Maxim Group LLC (“Maxim”), as the sole underwriter and book running manager. Maxim partially exercised its overallotment option that was granted to the Offering and purchased an additional 800,000 Warrants at a price of $0.0000001 per Warrant. Such exercised portion of the overallotment also closed on December 26, 2018.

Subsequently, Maxim partially exercised an additional portion of its overallotment option that was granted to the Offering and purchased an additional 500,000 shares of the Company’s Common Stock, resulting in gross proceeds of approximately $250,000.00 to the Company at the closing of such overallotment option on January 25, 2019.

The information furnished to this Item 7.01, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

About Applied DNA Sciences, Inc. (NASDAQ:APDN)

Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company’s platform ingredient, at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.

An ad to help with our costs